| PFKL | phosphofructokinase, liver type; 6-phosphofructo-2-kinase, liver type |
|---|---|
| PFKP | phosphofructokinase, platelet type; 6-phosphofructo-2-kinase, platelet type |
| AFB | Acid-Fast Bacillus(Type that causes Tuberculosis) |
| DMD | Duchenne type Muscular Dystrophy; 악성형 Duchenne형 근이영양증 |
| EA | 1) Esophageal Atresia Types 1. Esophageal Atresia with Dis... |
| immunization, passive | Transfer of immunity from immunised to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (adoptive transfer). (12 Dec 1998) |
|---|---|
| immunization, pneumococcal pneumonia | This vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease (copd) or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children. (12 Dec 1998) |
| immunization, polio | The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine). Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth. Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age. Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house. (12 Dec 1998) |
| immunization program | Organised services to administer immunization procedures in the prevention of various diseases. The programs are made available over a wide range of sites: schools, hospitals, public health agencies, voluntary health agencies, etc. They are administered to an equally wide range of population groups or on various administrative levels: community, municipal, state, national, international. (12 Dec 1998) |
| immunization, rubella | See Immunization, MMR. (12 Dec 1998) |
| immunization schedule | Schedule giving optimum times usually for primary and/or secondary immunization. (12 Dec 1998) |
| immunization, secondary | Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. (12 Dec 1998) |
| immunization, serum hepatitis | See Immunization, hepatitis b. (12 Dec 1998) |
| immunization, varicella zoster | See Immunization, chickenpox. (12 Dec 1998) |
| infectious hepatitis immunization | See Immunization, hepatitis a. (12 Dec 1998) |
| acrocephalosyndactyly type 1 | <paediatrics> An inherited disease (autosomal dominant) or a spontaneously occurring disease characterised by a peaked head and unusual facial appearance, due to the premature closure of the cranial sutures. A skull X-ray can confirm the diagnosis and treatment is surgical. Inheritance: autosomal dominant. (27 Sep 1997) |
| Alzheimer type I astrocyte | Enlarged frequently multinucleated astrocytes, seen in progressive multifocal leukoencephalopathy. (05 Mar 2000) |
| Alzheimer type II astrocyte | Enlarged astrocytes with vesicular nuclei and one or more small basophilic nucleoli, seen in hepatocerebral disease and Wilson's disease. (05 Mar 2000) |
| American Type Culture Collection | <cell culture> A key resource for cultured cells, located in Rockville, USA. (12 Dec 1998) |
| Antoni type A neurilemoma | <tumour> Relatively solid or compact arrangement of neoplastic tissue that consists of Schwann cells arranged in twisting bundles and associated with delicate reticulin fibres; the nuclei of the Schwann cells are frequently grouped in parallel rows (so-called palisades), and the nuclei and fibres sometimes form exaggerated tactile corpuscles, called Verocay bodies. (05 Mar 2000) |